Frontiers in Pharmacology | Renal Pharmacology

Review

Published on 09 Mar 2023

The emerging role of long non-coding RNAs in renal cell carcinoma progression and clinical therapy via targeting metabolic regulation

in Renal Pharmacology

Xingyu Gao
Haiying Zhang
Chang Zhang
Minghe Li
Xiao Yu
Yanan Sun
Yingai Shi
Hongxia Zhang
Xu He

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1122065

2,223 views
4 citations

Original Research

Published on 07 Mar 2023

Dapagliflozin alleviates renal fibrosis in a mouse model of adenine-induced renal injury by inhibiting TGF-β1/MAPK mediated mitochondrial damage

in Renal Pharmacology

Jianhua Zeng
Hao Huang
Yan Zhang
Xin Lv
Jiawei Cheng
Si Jue Zou
Yuanyuan Han
Songkai Wang
Li Gong
Zhangzhe Peng

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1095487

6,133 views
9 citations

Original Research

Published on 27 Feb 2023

Niaoduqing alleviates podocyte injury in high glucose model via regulating multiple targets and AGE/RAGE pathway: Network pharmacology and experimental validation

in Renal Pharmacology

Yipeng Fang
Yunfei Zhang
Chenxi Jia
Chunhong Ren
Xutao Zhao
Xin Zhang

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1047184

4,017 views
5 citations

Correction

Published on 27 Feb 2023

Corrigendum: MicroRNAs: Potential mediators between particulate matter 2.5 and Th17/Treg immune disorder in primary membranous nephropathy

in Renal Pharmacology

Xiaoshan Zhou
Haoran Dai
Hanxue Jiang
Hongliang Rui
Wenbin Liu
Zhaocheng Dong
Na Zhang
Qihan Zhao
Zhendong Feng
Yuehong Hu

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1166591

1,387 views
1 citation

Original Research

Published on 24 Feb 2023

Cell surface GRP78 regulates TGFβ1-mediated profibrotic responses via TSP1 in diabetic kidney disease

in Renal Pharmacology

Jackie Trink
Usman Ahmed
Kian O’Neil
Renzhong Li
Bo Gao
Joan C. Krepinsky

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1098321

3,054 views
6 citations

Original Research

Published on 15 Feb 2023

YY1-induced upregulation of LncRNA-ARAP1-AS2 and ARAP1 promotes diabetic kidney fibrosis via aberrant glycolysis associated with EGFR/PKM2/HIF-1α pathway

in Renal Pharmacology

Xin Li
Tian-Kui Ma
Min Wang
Xiao-Dan Zhang
Tian-Yan Liu
Yue Liu
Zhao-Hui Huang
Yong-Hong Zhu
Shuang Zhang
Li Yin

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1069348

4,656 views
6 citations

Review

Published on 15 Feb 2023

Therapeutic potential of artemisinin and its derivatives in managing kidney diseases

in Renal Pharmacology

Qi Jin
Tongtong Liu
Danqian Chen
Liping Yang
Huimin Mao
Fang Ma
Yuyang Wang
Ping Li
Yongli Zhan

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1097206

8,623 views
12 citations

Review

Published on 13 Feb 2023

Renin–angiotensin–aldosterone pathway modulators in chronic kidney disease: A comparative review

in Renal Pharmacology

Saeed Alshahrani

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1101068

12,957 views
12 citations

Review

Published on 09 Feb 2023

How to use COVID-19 antiviral drugs in patients with chronic kidney disease

in Renal Pharmacology

Ajinath Kale
Vishwadeep Shelke
Neha Dagar
Hans-Joachim Anders
Anil Bhanudas Gaikwad

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1053814

25,991 views
21 citations

Editorial

Published on 07 Feb 2023

Editorial: Model organisms in renal pharmacology: 2022

in Renal Pharmacology

Ayman M. Mahmoud
Weiqiang Lin
Vikram Patial
Rajesh Nachiappa Ganesh
Pragasam Viswanathan

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1139806

1,090 views

Original Research

Published on 06 Feb 2023

Network pharmacology, molecular docking, and experimental verification reveal the mechanism of San-Huang decoction in treating acute kidney injury

in Renal Pharmacology

Jiahui Liu
Zhongtang Li
Yunlan Lao
Xiaoming Jin
Yuzhi Wang
Beibei Jiang
Riming He
Shudong Yang

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1060464

6,256 views
7 citations

Review

Published on 06 Feb 2023

Advances of berberine against metabolic syndrome-associated kidney disease: Regarding effect and mechanism

in Renal Pharmacology

Ya-Fei Liu
Huan-Huan Wang
Yin-Hong Geng
Liang Han
Sheng-Hao Tu
Hui Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1112088

9,321 views
8 citations

Review

Published on 03 Feb 2023

Protein arginine methyltransferases in renal development, injury, repair, and fibrosis

in Renal Pharmacology

Jianjun Yu
Chao Yu
Georgia Bayliss
Shougang Zhuang

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1123415

2,569 views
2 citations

Review

Published on 30 Jan 2023

Autophagy and necroptosis in cisplatin-induced acute kidney injury: Recent advances regarding their role and therapeutic potential

in Renal Pharmacology

Noha Alassaf
Hala Attia

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1103062

6,977 views
20 citations

Original Research

Published on 17 Jan 2023

Gastrodin attenuates renal injury and collagen deposition via suppression of the TGF-β1/Smad2/3 signaling pathway based on network pharmacology analysis

in Renal Pharmacology

Ying Wen
Xiuli Zhang
Lihui Wei
Meizhu Wu
Ying Cheng
Huifang Zheng
Aling Shen
Changgeng Fu
Farman Ali
Linzi Long

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1082281

4,589 views
8 citations

Original Research

Published on 13 Jan 2023

Determination of HMGB1 in hepatitis B virus-related acute-on-chronic liver failure patients with acute kidney injury: Early prediction and prognostic implications

in Renal Pharmacology

Yu Liu
Wei Yuan
Miao Fang
Hongying Guo
Xin Zhang
Xue Mei
Yuyi Zhang
Longshan Ji
Yating Gao
Jiefei Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1031790

2,451 views
5 citations

Navigation group

Articles

The emerging role of long non-coding RNAs in renal cell carcinoma progression and clinical therapy via targeting metabolic regulation

Dapagliflozin alleviates renal fibrosis in a mouse model of adenine-induced renal injury by inhibiting TGF-β1/MAPK mediated mitochondrial damage

Niaoduqing alleviates podocyte injury in high glucose model via regulating multiple targets and AGE/RAGE pathway: Network pharmacology and experimental validation

Corrigendum: MicroRNAs: Potential mediators between particulate matter 2.5 and Th17/Treg immune disorder in primary membranous nephropathy

Cell surface GRP78 regulates TGFβ1-mediated profibrotic responses via TSP1 in diabetic kidney disease

YY1-induced upregulation of LncRNA-ARAP1-AS2 and ARAP1 promotes diabetic kidney fibrosis via aberrant glycolysis associated with EGFR/PKM2/HIF-1α pathway

Therapeutic potential of artemisinin and its derivatives in managing kidney diseases

Renin–angiotensin–aldosterone pathway modulators in chronic kidney disease: A comparative review

How to use COVID-19 antiviral drugs in patients with chronic kidney disease

Editorial: Model organisms in renal pharmacology: 2022

Network pharmacology, molecular docking, and experimental verification reveal the mechanism of San-Huang decoction in treating acute kidney injury

Advances of berberine against metabolic syndrome-associated kidney disease: Regarding effect and mechanism

Protein arginine methyltransferases in renal development, injury, repair, and fibrosis

Autophagy and necroptosis in cisplatin-induced acute kidney injury: Recent advances regarding their role and therapeutic potential

Gastrodin attenuates renal injury and collagen deposition via suppression of the TGF-β1/Smad2/3 signaling pathway based on network pharmacology analysis

Determination of HMGB1 in hepatitis B virus-related acute-on-chronic liver failure patients with acute kidney injury: Early prediction and prognostic implications